Inhibition of Aβ1-42 Aggregation
. Inhibition of Aβ1-42 aggregation.
Compound
Structure Inhibition of Aβ1-42 Aggregation at 10 µM (%) a 3Ab 13.6 ± 2.1 *
a Percent of inhibition at 10 µM compound and 1.5 µM Aβ1-42. Percentage of inhibition is expressed as mean ± standard deviation of two independent experiments. * p < 0.05, compared to the control (oneway ANOVA, followed by Bonferoni t-test). b n.a.; inhibition lower than 10%, compound defined as not active. c poor solubility in DMSO at 10 mM and 1 mM.
Compound 3Ab showed weak inhibition of Aβ1-42 aggregation, whereas other compound were not active.
Thioflavin-T (ThT) Fluorometric Assay [1]
Recombinant human 1,1,1,3,3,3-hexafluoro-2-propanol pretreated Aβ1-42 peptide (Merck Millipore, Darmstadt, Germany) was dissolved in DMSO to give 75 µM stock solution. The stock solution was further diluted in HEPES buffered solution (150 mM HEPES, pH 7.4, 150 mM NaCl), to 7.5 µM. Aβ1-42 solution was then added to the test compounds in black-walled 96-well plate, and diluted with ThT solution (final concentration of ThT was 10 µM). Final mixture contained 1.5 µM Aβ1-42, 10 µM of test compounds, and 3% DMSO. ThT fluorescence was measured every 5 min (λex = 440 nm, λem = 490 nm), with the medium continuously shaking between measurements using a 96-well microplate reader (Synergy™ H4, BioTek Instruments, Inc., Winooski, VT, USA). The fluorescence intensities at the plateau reached after 24 h in the absence and presence of the test compound were averaged, and the average fluorescence of the corresponding wells at t = 15 min was subtracted. The Aβ1-42 aggregation inhibitory potency is expressed as the percentage inhibition (% inh = (1 − Fi/F0) × 100%), where Fi is the increase in fluorescence of Aβ1-42 treated with the test compound, and F0 is the increase in fluorescence of Aβ1-42 alone.
